Mainland China - AI Drug Mining Platform

The company has developed a proprietary deep learning algorithm system and created a drug mining platform that integrates screening, design, projection, optimisation and other functions into one. A number of models has been established, including the screening of phosphatase inhibitors for KRAS tumours. This ensures significant reduction of R&D costs and improved screening accuracy of a magnitude of four orders, and provides a fast, cheaper and accurate new drug cooperative development platform for global R&D institutions.